Payne F, Dabb A, Harrison J, Sammut I
Int J Mol Sci. 2024; 25(17).
PMID: 39273196
PMC: 11395567.
DOI: 10.3390/ijms25179247.
Al Mamun A, Shao C, Geng P, Wang S, Xiao J
J Inflamm Res. 2024; 17:3839-3864.
PMID: 38895141
PMC: 11185259.
DOI: 10.2147/JIR.S465203.
Wang Y, Luo J, Guan X, Zhao Y, Sun L
Cell Death Discov. 2024; 10(1):122.
PMID: 38458999
PMC: 10923922.
DOI: 10.1038/s41420-024-01887-7.
Singh S, Sharma S, Sharma H
Curr Pharm Biotechnol. 2024; 25(13):1719-1746.
PMID: 38173061
DOI: 10.2174/0113892010276859231125165251.
Bulte D, Rigamonti C, Romano A, Mortellaro A
Cells. 2023; 12(13).
PMID: 37443800
PMC: 10340308.
DOI: 10.3390/cells12131766.
NOD-like Receptors-Emerging Links to Obesity and Associated Morbidities.
Bauer S, Hezinger L, Rexhepi F, Ramanathan S, Kufer T
Int J Mol Sci. 2023; 24(10).
PMID: 37239938
PMC: 10218625.
DOI: 10.3390/ijms24108595.
NLRP3 inflammasome: The rising star in cardiovascular diseases.
Zheng Y, Xu L, Dong N, Li F
Front Cardiovasc Med. 2022; 9:927061.
PMID: 36204568
PMC: 9530053.
DOI: 10.3389/fcvm.2022.927061.
Oral Nanocurcumin Alone or in Combination with Insulin Alleviates STZ-Induced Diabetic Neuropathy in Rats.
Dwivedi S, Gottipati A, Ganugula R, Arora M, Friend R, Osburne R
Mol Pharm. 2022; 19(12):4612-4624.
PMID: 36106748
PMC: 9972482.
DOI: 10.1021/acs.molpharmaceut.2c00465.
Role of NLRP3 Inflammasome and Its Inhibitors as Emerging Therapeutic Drug Candidate for Alzheimer's Disease: a Review of Mechanism of Activation, Regulation, and Inhibition.
Sharma B, Satija G, Madan A, Garg M, Alam M, Shaquiquzzaman M
Inflammation. 2022; 46(1):56-87.
PMID: 36006570
PMC: 9403980.
DOI: 10.1007/s10753-022-01730-0.
Pro- and anti-inflammatory bioactive lipids imbalance contributes to the pathobiology of autoimmune diseases.
Das U
Eur J Clin Nutr. 2022; 77(6):637-651.
PMID: 35701524
DOI: 10.1038/s41430-022-01173-8.
Targeting NLRP3 Inflammasome in the Treatment Of Diabetes and Diabetic Complications: Role of Natural Compounds from Herbal Medicine.
Bai Y, Mu Q, Bao X, Zuo J, Fang X, Hua J
Aging Dis. 2021; 12(7):1587-1604.
PMID: 34631209
PMC: 8460305.
DOI: 10.14336/AD.2021.0318.
Beyond Homeostasis: Potassium and Pathogenesis during Bacterial Infections.
Do E, Gries C
Infect Immun. 2021; 89(7):e0076620.
PMID: 33875474
PMC: 8486168.
DOI: 10.1128/IAI.00766-20.
Juglone Suppresses LPS-induced Inflammatory Responses and NLRP3 Activation in Macrophages.
Kim N, Kim H, Lee J, Jo S, Won H, Lee G
Molecules. 2020; 25(13).
PMID: 32646056
PMC: 7412499.
DOI: 10.3390/molecules25133104.
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation.
Kelley N, Jeltema D, Duan Y, He Y
Int J Mol Sci. 2019; 20(13).
PMID: 31284572
PMC: 6651423.
DOI: 10.3390/ijms20133328.
Bacterial Control of Pores Induced by the Type III Secretion System: Mind the Gap.
Guignot J, Tran van Nhieu G
Front Immunol. 2016; 7:84.
PMID: 27014264
PMC: 4783396.
DOI: 10.3389/fimmu.2016.00084.
TNF-Α may mediate inflammasome activation in the absence of bacterial infection in more than one way.
Alvarez S, Munoz-Fernandez M
PLoS One. 2013; 8(8):e71477.
PMID: 23940760
PMC: 3737100.
DOI: 10.1371/journal.pone.0071477.
Visualization of bacterial toxin induced responses using live cell fluorescence microscopy.
Keyel P, Heid M, Watkins S, Salter R
J Vis Exp. 2012; (68):e4227.
PMID: 23052609
PMC: 3490310.
DOI: 10.3791/4227.
Smooth muscle-specific expression of calcium-independent phospholipase A2β (iPLA2β) participates in the initiation and early progression of vascular inflammation and neointima formation.
Liu S, Xie Z, Zhao Q, Pang H, Turk J, Calderon L
J Biol Chem. 2012; 287(29):24739-53.
PMID: 22637477
PMC: 3397901.
DOI: 10.1074/jbc.M112.340216.
Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation.
Das U
J Inflamm Res. 2011; 3:143-70.
PMID: 22096364
PMC: 3218729.
DOI: 10.2147/JIR.S9425.
Regulation of WNK1 kinase by extracellular potassium.
Naito S, Ohta A, Sohara E, Ohta E, Rai T, Sasaki S
Clin Exp Nephrol. 2010; 15(2):195-202.
PMID: 21107632
DOI: 10.1007/s10157-010-0378-9.